EDGAR·FLOW

Basel Medical Group Ltd — Form F-1

Filed September 17, 2026 · analyzed by the Registration Agent
F-1 — Neutral significance 28/100
What the filing says
Basel Medical Group Ltd (BVI company) filed Form F-1 to register up to 6,000,000 units for sale, each unit comprising one ordinary share (or pre-funded warrant) plus one common warrant. Cathay Securities acts as placement agent on best-efforts basis. Company will pay placement agent 6% cash fee (capped at US$400,000) plus up to US$60,000 in expenses. Specific offering price, number of units sold, and investor names are redacted [*]. Registration statement became effective [*], 2026. Company covenants 180-day lock-up on new equity issuances and grants placement agent 6-month right of first refusal on future capital raises.
Why this rating

Standard equity registration filing; no dollar amounts disclosed due to redactions. Routine FINRA-compliant capital raising structure with conventional terms. Immaterial without concrete offering size.

View original filing on SEC.gov ↗ BMGL · stock on Yahoo Finance ↗

See more from September 17, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.